PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Exelon, Exelon Patch

What is Rivastigmine? Rivastigmine is a cholinergic agent that was developed by Novartis for the treatment of mild to moderate dementia of the Alzheimer’s type. Rivastigmine has been available in capsule and liquid formulations since 1997. In 2006, it became the first product approved for Parkinson's disease dementia. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

13 patients in the community are taking or have taken Rivastigmine.

Reason # Patients Percentage of patients
Memory problems 5 38%
Brain fog 4 30%
Other 3 23%
Stiffness/spasticity 1 7%

Dosages

Based on the patients currently taking Rivastigmine.

  0 mg day 3 mg day 6 mg day 9.5 mg day 9.6 mg day 12 mg day 300 mg day
  1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Rivastigmine or how long patients were taking Rivastigmine before stopping.

Currently taking Rivastigmine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
3
1
2

Stopped taking Rivastigmine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
0
1
0
0
Why Patients Stopped Taking Rivastigmine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 2 67% Side effects too severe: 67%
Did not seem to work 1 33% Did not seem to work: 33%
Not indicated 1 33% Not indicated: 33%


Back to top